Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Predicting school readiness from neurodevelopmental assessments at age 2 years after respiratory distress syndrome in infants born preterm.
Inferior Clinical Outcomes for Patients with Medicaid Insurance After Surgery for Degenerative Lumbar Spondylolisthesis: A Prospective Registry Analysis of 608 Patients.
Influenza-associated deaths among children in the United States, 2003-2004.
Halobacterium
Vedolizumab as induction and maintenance therapy for Crohn's disease.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013 Aug 22; 369(8):711-21.
View in:
PubMed
subject areas
Adult
Antibodies
Antibodies, Monoclonal, Humanized
Crohn Disease
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Female
Glucocorticoids
Humans
Immunosuppressive Agents
Induction Chemotherapy
Infusions, Intravenous
Integrins
Maintenance Chemotherapy
Male
Middle Aged
authors with profiles
Stephen B. Hanauer